556 related articles for article (PubMed ID: 33542947)
1. From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Hartl N; Adams F; Merkel OM
Adv Ther (Weinh); 2021 Jan; 4(1):. PubMed ID: 33542947
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier.
Wünsch A; Mulac D; Langer K
Int J Pharm; 2020 Nov; 589():119821. PubMed ID: 32861770
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter J; Shamenkov D; Petrov V; Ramge P; Cychutek K; Koch-Brandt C; Alyautdin R
J Drug Target; 2002 Jun; 10(4):317-25. PubMed ID: 12164380
[TBL] [Abstract][Full Text] [Related]
4. Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells.
Moya ELJ; Lombardo SM; Vandenhaute E; Schneider M; Mysiorek C; Türeli AE; Kanda T; Shimizu F; Sano Y; Maubon N; Gosselet F; Günday-Türeli N; Dehouck MP
Int J Pharm; 2022 Jun; 621():121780. PubMed ID: 35504427
[TBL] [Abstract][Full Text] [Related]
5. Lecithin coating as universal stabilization and functionalization strategy for nanosized drug carriers to overcome the blood-brain barrier.
Wünsch A; Mulac D; Langer K
Int J Pharm; 2021 Jan; 593():120146. PubMed ID: 33279714
[TBL] [Abstract][Full Text] [Related]
6. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
Kreuter J
J Nanosci Nanotechnol; 2004 May; 4(5):484-8. PubMed ID: 15503433
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticulate systems for brain delivery of drugs.
Kreuter J
Adv Drug Deliv Rev; 2001 Mar; 47(1):65-81. PubMed ID: 11251246
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB).
Kreuter J
J Microencapsul; 2013; 30(1):49-54. PubMed ID: 22676632
[TBL] [Abstract][Full Text] [Related]
9. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.
Nishitsuji K; Hosono T; Nakamura T; Bu G; Michikawa M
J Biol Chem; 2011 May; 286(20):17536-42. PubMed ID: 21471207
[TBL] [Abstract][Full Text] [Related]
11. ApoE-functionalization of nanoparticles for targeted brain delivery-a feasible method for polyplexes?
Hartl N; Gabold B; Uhl P; Kromer A; Xiao X; Fricker G; Mier W; Liu R; Merkel OM
Drug Deliv Transl Res; 2024 Jun; 14(6):1660-1677. PubMed ID: 38087181
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier.
Kratzer I; Wernig K; Panzenboeck U; Bernhart E; Reicher H; Wronski R; Windisch M; Hammer A; Malle E; Zimmer A; Sattler W
J Control Release; 2007 Feb; 117(3):301-11. PubMed ID: 17239472
[TBL] [Abstract][Full Text] [Related]
13. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
14. A combination of receptor mediated transcytosis and photothermal effect promotes BBB permeability and the treatment of meningitis using itraconazole.
Zhang SS; Asghar S; Ye JX; Lin L; Ping QN; Chen ZP; Shao F; Xiao YY
Nanoscale; 2020 Dec; 12(46):23709-23720. PubMed ID: 33231242
[TBL] [Abstract][Full Text] [Related]
15. ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood-Brain Barrier.
Topal GR; Mészáros M; Porkoláb G; Szecskó A; Polgár TF; Siklós L; Deli MA; Veszelka S; Bozkir A
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33383743
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood-Brain Barrier.
Song Y; Du D; Li L; Xu J; Dutta P; Lin Y
ACS Appl Mater Interfaces; 2017 Jun; 9(24):20410-20416. PubMed ID: 28541655
[TBL] [Abstract][Full Text] [Related]
17. Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.
Portioli C; Bovi M; Benati D; Donini M; Perduca M; Romeo A; Dusi S; Monaco HL; Bentivoglio M
J Biomed Mater Res A; 2017 Mar; 105(3):847-858. PubMed ID: 27885823
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E.
Kuo YC; Rajesh R
Int J Pharm; 2017 Aug; 528(1-2):228-241. PubMed ID: 28549973
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
Kreuter J
Adv Drug Deliv Rev; 2014 May; 71():2-14. PubMed ID: 23981489
[TBL] [Abstract][Full Text] [Related]
20.
Peng B; Tong Z; Tong WY; Pasic PJ; Oddo A; Dai Y; Luo M; Frescene J; Welch NG; Easton CD; Thissen H; Voelcker NH
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56753-56766. PubMed ID: 33226228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
